KHKathryn S. Hatch

Kathryn S. Hatch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kathryn S. Hatch has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Conformation governs cellular behaviors of LRRK2 Parkinson’s disease variants

    by Kathryn S. Hatch, Katherine J. Surridge, Wei Gai, Brookelyn Quan, Gaurav Kumar, Nicholas Lattal, Robert Abrisch, Niels Pagani, Andres E. Leschziner, Samara L. Reck-Peterson

    Gain-of-function of leucine-rich repeat kinase 2 (LRRK2) is a common cause of Parkinson’s disease (PD). In its autoinhibited state, the leucine-rich repeats of LRRK2 block the kinase active site, preventing substrate phosphorylation. Displacing the repeats (‘unlatching’) primes LRRK2 for activity. Preferential unlatching causes increased substrate phosphorylation of the PD allele LRRK2[R1441H], but not LRRK2[G2019S]. Here, we define a large class of PD-associated ‘unlatching’ mutations based on their effect on LRRK2 conformation. Unlatching mutants show increased localization to membranes, the site of LRRK2’s Rab substrates. Unlatching mutants are also characterized by decreased LRRK2 S935 phosphorylation, which we define as a biomarker of conformation. This framework resolves the mechanism of variants such as I2020T, which structural studies could not predict. Overall, we establish unlatching as a unifying mechanism for most PD-linked variants and describe measurable readouts for identifying LRRK2-driven disease.

  • Open Access

    Single particle of LRRK2 C-terminal half bound to E11 DARPin

    by Dederer V, Sanz Murillo M, Karasmanis Ep, Hatch Ks, Chatterjee D, Preuss F, Abdul Azeez Kr, Nguyen Lv, Galicia C, Dreier B, et al.

    EMPIAR, the Electron Microscopy Public Image Archive centered at EMBL-EBI, is a public resource for raw electron microscopy images related to EMDB, contains micrographs, particle sets and tilt-series.

  • Open Access

    Short 5’ UTRs serve as a marker for viral mRNA translation inhibition by the IFIT2-IFIT3 antiviral complex

    by Dustin R. Glasner, Candace Todd, Brian Cook, Agustina D’urso, Shivani Khosla, Elena Estrada, Jaxon D. Wagner, Mason D. Bartels, Pierce Ford, Jordan Prych, et al.

    Recognition of “non-self” nucleic acids, including cytoplasmic dsDNA, dsRNA, or mRNAs lacking proper 5’ cap structures, is critical for the innate immune response to viruses. Here, we demonstrate that short 5’ untranslated regions (UTRs), a characteristic of many viral mRNAs, can also serve as a molecular pattern for innate immune recognition via the interferon-induced proteins IFIT2 and IFIT3. The IFIT2-IFIT3 heterodimer, formed through an intricate domain swap structure resolved by cryo-EM, mediates viral mRNA 5’ end recognition, translation inhibition, and ultimately antiviral activity. Critically, 5’ UTR lengths <50 nucleotides are necessary and sufficient to sensitize an mRNA to translation inhibition by the IFIT2-IFIT3 complex. Accordingly, diverse viruses whose mRNAs contain short 5’ UTRs, such as vesicular stomatitis virus and parainfluenza virus 3, are sensitive to IFIT2-IFIT3-mediated antiviral activity. Our work thus reveals a pattern of antiviral nucleic acid immune recognition that takes advantage of the inherent constraints on viral genome size.


  • Open Access

    A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

    by Verena Dederer, Marta Sanz Murillo, Eva P. Karasmanis, Kathryn S. Hatch, Deep Chatterjee, Franziska Preuss, Kamal R. Abdul Azeez, Landon Vu Nguyen, Christian Galicia, Birgit Dreier, et al.


  • Open Access

    Visualization of LRRK2 filaments in 293T cells v1

    by Eva Karasmanis, Kathryn S Hatch

    Visualization of LRRK2 filaments in 293T cells GOAL: Express GFP-LRRK2 with or without DARPin E11 and quantify the percentage of cells with LRRK2 filaments in the presence and absence of MLi-2 in 293T cells.